We have brought together the recommendations of a working group composed of experts from the public and private sectors on how to best benefit from recent advances in AI and how to generate, format and disseminate data to enable future breakthroughs in AI-guided drug discovery.
Toronto, Ontario – July 3, 2024 – The Structural Genomics Consortium (SGC) is pleased to announce the appointment of Dr. Peter Sampson as the new Vice President of Drug Discovery and Development for SGC’s affiliate Canadian charity, Agora Open Science Trust (Agora).
